Location

Republic of Belarus 220013, Minsk, Brovki Street, 3, build. 3

Phone

+ 375 17 290-98-38

BelMAPE at the conference of the European Regional Office of the International Diabetes Federation

BelMAPE at the conference of the European Regional Office of the International Diabetes Federation

2022-12-09 09:28:00

On December 2–9, 2022, associate professor of the Department of Endocrinology of BelMAPE, Candidate of Medical Sciences, associate professor Lushchik M. L. took part in the conference of the European Regional Office of the International Diabetes Federation, which was held in Lisbon (Portugal).

As part of the exhibition of diabetological societies, the booth of the Republic of Belarus presented poster information about the work of the School of Diabetes BelMAPE-BEO (public association "Belarusian Society of Endocrinologists"), educational seminars and conferences held for family members of patients with diabetes mellitus, patients themselves, doctors and nurses.

A separate stand was devoted to the training of doctors at BelMAPE, including at the Department of Endocrinology in various aspects of diabetology.

Particular emphasis is placed on postgraduate training at BelMAPE for foreign citizens, the possibilities of medical diagnostics and treatment in the Republic of Belarus within the framework of the “Clinics of Belarus” project.

During the poster session, Associate Professor of the Department of Endocrinology Maxim Lushchik made a presentation on the ongoing work at BelMAPE to improve the technologies for training doctors in diabetology, the effectiveness of the online School of Diabetes.

In a discussion about the importance of training all members of the “diabetes team”, the Georgian delegation expressed its readiness to participate in joint educational projects.

The General Assembly of the International Diabetes Federation (Lisbon, December 4–5, 2022), in which affiliated public associations of endocrinologists and patient societies took part, proclaimed one of the main tasks by 2030 to achieve ideal compensation of metabolic parameters in 80% of patients with diabetes mellitus, reducing the risk of cardiovascular and other complications. One of their goals by 2030 was to make statins mandatory for all patients with diabetes mellitus over the age of 45.

 

Share: